Literature DB >> 33178344

Long non-coding RNA RPSAP52 upregulates Timp3 by serving as the endogenous sponge of microRNA-365 in diabetic retinopathy.

Tongtong Niu1, Yan An1, Tingting Lv1, Dongning Liu1.   

Abstract

Diabetic retinopathy (DR) is a serious complication of diabetes and the most common metabolic disorder. Recently, long non-coding (lnc)RNAs have been identified as critical regulators of DR. Ribosomal protein SA pseudogene 52 (RPSAP52) is an oncogenic lncRNA expressed in pituitary tumors. The present study aimed to investigate the functions of RPSAP52 in DR. RPSAP52 levels in the plasma of diabetic patients with or without DR complication was detected. Luciferase reporter assays, RT-qPCR and western blotting were performed to detect the interaction between RPSAP52 and micro RNA (miR)-365. Moreover, expression vectors of RPSAP52 and Timp3, as well as miR-365 mimics were transfected into ARPE-19 cells exposed to high glucose and the apoptotic cells were detected. The results showed that RPSAP52 was downregulated in patients with DR compared with patients with diabetes without obvious complications. RPSAP52 directly interacted with miR-365, while overexpression of RPSAP52 and miR-365 did not affect the expression of one another. In addition, overexpression of RPSAP52 upregulated TIMP metallopeptidase inhibitor 3 (Timp3) in retinal pigment epithelial (RPE) cells. High glucose treatment led to downregulated RPSAP52 and Timp3, but upregulated miR-365 in RPE cells. Moreover, cell apoptosis analysis identified that overexpression of RPSAP52 and Timp3 led to a decreased apoptotic rate of RPE cells under high glucose treatment. Therefore, it was speculated that RPSAP52 may upregulate Timp3 by serving as the endogenous sponge of miR-365 in DR to suppress RPE cell apoptosis.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  TIMP metallopeptidase inhibitor 3; apoptosis; diabetic retinopathy; microRNA-365; ribosomal protein SA pseudogene 52

Year:  2020        PMID: 33178344      PMCID: PMC7651866          DOI: 10.3892/etm.2020.9376

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  27 in total

1.  microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2.

Authors:  Jing Nie; Lin Liu; Wei Zheng; Lin Chen; Xin Wu; Yingxin Xu; Xiaohui Du; Weidong Han
Journal:  Carcinogenesis       Date:  2011-11-09       Impact factor: 4.944

Review 2.  Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium.

Authors:  Tina Xia; Lawrence J Rizzolo
Journal:  Vision Res       Date:  2017-03-30       Impact factor: 1.886

3.  MicroRNA in aqueous humor from patients with cataract.

Authors:  Jeffrey J Dunmire; Evan Lagouros; Rachida A Bouhenni; Marc Jones; Deepak P Edward
Journal:  Exp Eye Res       Date:  2012-11-09       Impact factor: 3.467

4.  Long noncoding RNA BDNF-AS inversely regulated BDNF and modulated high-glucose induced apoptosis in human retinal pigment epithelial cells.

Authors:  Yanyan Li; Feng Xu; Hanyan Xiao; Feng Han
Journal:  J Cell Biochem       Date:  2017-10-05       Impact factor: 4.429

5.  MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.

Authors:  Yanli Wang; Chunling Xu; Yun Wang; Xiaomeng Zhang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

6.  MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus.

Authors:  Ebony Liu; Georgia Kaidonis; Bennet J McComish; Mark C Gillies; Sotoodeh Abhary; Rohan W Essex; John H Chang; Bishwanath Pal; Mark Daniell; Stewart Lake; Nikolai Petrovsky; Alex W Hewitt; Alicia Jenkins; Ecosse L Lamoureux; Jonathan M Gleadle; Jamie E Craig; Kathryn P Burdon
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-09-03       Impact factor: 4.799

7.  CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.

Authors:  Jiaxin Liang; Mengqian Chen; Daniel Hughes; Alexander A Chumanevich; Serena Altilia; Vimala Kaza; Chang-Uk Lim; Hippokratis Kiaris; Karthikeyan Mythreye; Maria Marjorette Pena; Eugenia V Broude; Igor B Roninson
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

8.  RPSAP52 lncRNA is overexpressed in pituitary tumors and promotes cell proliferation by acting as miRNA sponge for HMGA proteins.

Authors:  Daniela D'Angelo; Paula Mussnich; Romina Sepe; Maddalena Raia; Luigi Del Vecchio; Paolo Cappabianca; Simona Pellecchia; Sara Petrosino; Serena Saggio; Domenico Solari; Filippo Fraggetta; Alfredo Fusco
Journal:  J Mol Med (Berl)       Date:  2019-05-10       Impact factor: 4.599

9.  Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.

Authors:  Savalan Babapoor-Farrokhran; Kathleen Jee; Brooks Puchner; Syed Junaid Hassan; Xiaoban Xin; Murilo Rodrigues; Fabiana Kashiwabuchi; Tao Ma; Ke Hu; Monika Deshpande; Yassine Daoud; Sharon Solomon; Adam Wenick; Gerard A Lutty; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

10.  Genetic components in diabetic retinopathy.

Authors:  Bibhudatta Mishra; Anand Swaroop; Raj P Kandpal
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

View more
  1 in total

1.  LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer.

Authors:  Chao He; Yuanyuan Liu; Jinhou Li; Xiao Zheng; Jianwei Liang; Gang Cui; Hong Chang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.